TY - JOUR
T1 - The existence of a second allosteric site on the M1 muscarinic acetylcholine receptor and its implications for drug design
AU - Espinoza-Fonseca, L. Michel
AU - Trujillo-Ferrara, José G.
N1 - Funding Information:
The authors thank Edward C. Hulme for kindly providing the coordinates of the homology model of the M 1 muscarinic receptor and Asya Varbanova for her careful review of the manuscript. This work was supported by grants from CONACYT and CGPI-IPN to J.G.T.F and from the Department of Biochemistry, Structural Biology and Biophysics, University of Minnesota, and the Minnesota Supercomputing Institute to L.M.E.F.
PY - 2006/3/1
Y1 - 2006/3/1
N2 - Fully flexible docking of KT5720, an allosteric modulator of the muscarinic receptors, was performed on a dynamic model of the M1 muscarinic acetylcholine receptor. The results confirmed the existence of a second allosteric site, located on the intracellular face of the receptor. These results would be beneficial for the design of modulators of this receptor to be used as an effective alternative against the Alzheimer's disease.
AB - Fully flexible docking of KT5720, an allosteric modulator of the muscarinic receptors, was performed on a dynamic model of the M1 muscarinic acetylcholine receptor. The results confirmed the existence of a second allosteric site, located on the intracellular face of the receptor. These results would be beneficial for the design of modulators of this receptor to be used as an effective alternative against the Alzheimer's disease.
KW - Alzheimer's disease
KW - Blind docking
KW - M muscarinic receptor
KW - Molecular dynamics simulations
KW - Multiple allosteric sites
KW - Relax complex scheme
KW - Staurosporine derivatives
UR - http://www.scopus.com/inward/record.url?scp=31344434532&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2005.11.097
DO - 10.1016/j.bmcl.2005.11.097
M3 - Artículo
C2 - 16364641
SN - 0960-894X
VL - 16
SP - 1217
EP - 1220
JO - Bioorganic and Medicinal Chemistry Letters
JF - Bioorganic and Medicinal Chemistry Letters
IS - 5
ER -